BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2872592)

  • 21. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
    Maton PN; Gardner JD; Jensen RT
    Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metastatic glucagonoma. Complete remission by dacarbazine (5 years' recession)].
    Jeanmougin M; Civatte J; Bonvalet D; Passa P; Verola O; Zylberait D
    Ann Dermatol Venereol; 1988; 115(8):833-8. PubMed ID: 2849362
    [No Abstract]   [Full Text] [Related]  

  • 23. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
    Santangelo WC; Dueno MI; Krejs GJ
    Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
    [No Abstract]   [Full Text] [Related]  

  • 24. Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug?
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH
    Neth J Med; 1989 Aug; 35(1-2):86-94. PubMed ID: 2550827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
    Glaser B; Rösler A; Halperin Y
    Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Somatostatin analogue in the treatment of neuroendocrine gut tumors].
    Ben Yosef R; Glaser B; Catane R
    Harefuah; 1990 Jul; 119(1-2):15-8. PubMed ID: 2172125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of somatostatinoma: responses to food and SMS 201-995 administration.
    Davis TM; Bray G; Domin J; Bloom SR
    Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.
    Christensen C
    Acta Chir Scand; 1989 Oct; 155(10):541-3. PubMed ID: 2557717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors.
    Maton PN
    Gastroenterol Clin North Am; 1989 Dec; 18(4):897-922. PubMed ID: 2559036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagonoma syndrome.
    Bloom SR; Polak JM
    Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
    Ligorria C; Montaña E; Virgili N
    Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-acting somatostatin analog SMS 201-955 (Sandostatin) and its application in clinical gastroenterological practice].
    Meier R; Gyr K
    Schweiz Rundsch Med Prax; 1988 Aug; 77(31-32):813-9. PubMed ID: 2845555
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.
    Kraenzlin ME; Ch'ng JL; Wood SM; Carr DH; Bloom SR
    Gastroenterology; 1985 Jan; 88(1 Pt 1):185-7. PubMed ID: 2856877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis.
    Tsai ST; Eckhauser FE; Thompson NW; Strodel WE; Vinik AI
    Surgery; 1986 Oct; 100(4):788-95. PubMed ID: 2876529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma.
    Koelz A; Kraenzlin M; Gyr K; Meier V; Bloom SR; Heitz P; Stalder H
    Gastroenterology; 1987 Feb; 92(2):527-31. PubMed ID: 2878857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preoperative treatment of hypoglycemia caused by an insulinoma with the somatostatin analog SMS 201-995].
    Sánchez García Cervigón P; Fernández Navarro JI; Salmerón de Diego J; Caballero Asensi A; Cornelio Hernández F; Jara Albarrán A
    Med Clin (Barc); 1987 Oct; 89(12):511-3. PubMed ID: 2890800
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.
    Alberts AS; Falkson G
    S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endocrine-active gastrointestinal tumors: are there any new therapeutic possibilities?].
    Marbet UA; Kraenzlin M; Gyr K; Stalder GA
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1120-3. PubMed ID: 2426077
    [No Abstract]   [Full Text] [Related]  

  • 40. Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide.
    Longnecker SM
    Drug Intell Clin Pharm; 1988 Feb; 22(2):136-8. PubMed ID: 2894965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.